Ronald E. Osman - 04 May 2026 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: INTI
Reported as of: 04 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Aug 2026, 13:33:26 UTC
Prior SEC filing: 16 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Ronald E. Osman

Key filing fact

Ronald E. Osman filed Form 4 for Inhibitor Therapeutics, Inc. (INTI) on 04 Aug 2026.

Key facts

This page summarizes Ronald E. Osman's Form 4 filing for Inhibitor Therapeutics, Inc. (INTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Aug 2026, 13:33.

Change

Previous filing in this sequence was filed on 16 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001380466 Primary reporting owner

OSMAN RONALD E

Relationship: Director, 10%+ Owner
Address: 241 AQUAMSI ST, CAPE GIRARDEAU
Signature: /s/ Ronald E. Osman
Signature date: 04 Aug 2026

CIK 0001972372

Ronald E Osman Irrevocable Trust III

Relationship: 10%+ Owner
Address: 241 AQUAMSI ST, CAPE GIRARDEAU
Signature: /s/ Ronald E. Osman trustee of the Ronald E. Osman Trust III
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INTI transaction

Common Stock

Award

Transaction value
Shares: +50,000
Change %: +0.21%
Price: $0.000000^*
Shares after: 23,614,985
Date: 04 May 2026
Ownership: See Footnotes
Footnotes: F1, F2

INTI transaction

Common Stock

Award

Transaction value
Shares: +50,000
Change %: +0.21%
Price: $0.000000^*
Shares after: 23,614,985
Date: 04 May 2026
Ownership: See Footnotes
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan, subject to shareholder approval.

Footnote F2

These shares represent 100,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III.